Literature DB >> 22533718

Cyclosporin A and tacrolimus reduce T-cell polyfunctionality but not interferon-γ responses directed at cytomegalovirus.

Stephan Fuhrmann1, Raskit Lachmann, Mathias Streitz, Roland Hetzer, Hans-Dieter Volk, Hans Lehmkuhl, Florian Kern.   

Abstract

Cytomegalovirus (CMV) -specific immunity is often estimated by the number of in vitro CMV antigen-inducible interferon-γ-positive (IFN-γ(+) ) T cells. However, recent work indicates that simultaneous production of IFN-γ, tumour necrosis factor-α (TNF-α) and interleukin-2 (IL-2) (referred to as 'polyfunctionality') is more relevant for anti-viral protection. Here, we compared polyfunctionality of CMV-specific T cells (pp65 and IE-1 proteins) in 23 solid-organ transplant patients and seven healthy controls by flow cytometry. The proportions of TNF-α(+) /IFN-γ(+) /IL-2 cells among the activated cells were significantly reduced in transplant patients but not the frequencies of IFN-γ(+) CD8(+) T cells. Immunosuppression reduces polyfunctionality, which reflects the increased infection risk in this patient group.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22533718      PMCID: PMC3401979          DOI: 10.1111/j.1365-2567.2012.03594.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

Review 1.  Mapping T cell epitopes by flow cytometry.

Authors:  Bodo Hoffmeister; Felix Kiecker; Lydia Tesfa; Hans-Dieter Volk; Louis J Picker; Florian Kern
Journal:  Methods       Date:  2003-03       Impact factor: 3.608

2.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

Review 3.  Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.

Authors:  Giuseppe Pantaleo; Richard A Koup
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

4.  Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study.

Authors:  Jan W Gratama; Michael Boeckh; Ryotaro Nakamura; Jan J Cornelissen; Rik A Brooimans; John A Zaia; Stephen J Forman; Karl Gaal; Kurtis R Bray; Gail H Gasior; Christopher S Boyce; Linda A Sullivan; Paula C Southwick
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

5.  Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications.

Authors:  Yves Chalandon; Sylvie Degermann; Jean Villard; Lionel Arlettaz; Laurent Kaiser; Solange Vischer; Steffen Walter; Mirjam H M Heemskerk; Rene A W van Lier; Claudine Helg; Bernard Chapuis; Eddy Roosnek
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

Review 6.  Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer.

Authors:  Florian Kern; Giuseppina LiPira; Jan W Gratama; Fabrizio Manca; Mario Roederer
Journal:  Trends Immunol       Date:  2005-09       Impact factor: 16.687

Review 7.  Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients.

Authors:  Florencia Pereyra; Robert H Rubin
Journal:  Curr Opin Infect Dis       Date:  2004-08       Impact factor: 4.915

8.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

Authors:  P Reusser; S R Riddell; J D Meyers; P D Greenberg
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

9.  Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients.

Authors:  G Gerna; D Lilleri; V Rognoni; M Agozzino; F Meloni; T Oggionni; C Pellegrini; E Arbustini; A M D'Armini
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

10.  Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers.

Authors:  Mark Cobbold; Naeem Khan; Batoul Pourgheysari; Sudhir Tauro; Dorothy McDonald; Husam Osman; Mario Assenmacher; Lucinda Billingham; Colin Steward; Charles Crawley; Eduardo Olavarria; John Goldman; Ronjon Chakraverty; Premini Mahendra; Charles Craddock; Paul A H Moss
Journal:  J Exp Med       Date:  2005-08-01       Impact factor: 14.307

View more
  7 in total

1.  Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells.

Authors:  Lars Tramsen; Stanislaw Schmidt; Frauke Roeger; Ralf Schubert; Emilia Salzmann-Manrique; Jean-Paul Latgé; Thomas Klingebiel; Thomas Lehrnbecher
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

Review 2.  Flow cytometry and solid organ transplantation: a perfect match.

Authors:  Orla Maguire; Joseph D Tario; Thomas C Shanahan; Paul K Wallace; Hans Minderman
Journal:  Immunol Invest       Date:  2014       Impact factor: 3.657

3.  Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents.

Authors:  Philip J Cooper; Monika Esser; Arnaud Marchant; Kinga K Smolen; Bing Cai; Edgardo S Fortuno; Laura Gelinas; Martin Larsen; David P Speert; Mustapha Chamekh; Tobias R Kollmann
Journal:  J Immunol       Date:  2014-08-18       Impact factor: 5.422

4.  Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients.

Authors:  Mario Fernández-Ruiz; Patricia Almendro-Vázquez; Octavio Carretero; Tamara Ruiz-Merlo; Rocío Laguna-Goya; Rafael San Juan; Francisco López-Medrano; Estéfani García-Ríos; Vicente Más; Miguel Moreno-Batenero; Carmelo Loinaz; Amado Andrés; Pilar Pérez-Romero; Estela Paz-Artal; José María Aguado
Journal:  Transplant Direct       Date:  2021-11-17

5.  Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism.

Authors:  Carsten Gründemann; Kathrin Thell; Karin Lengen; Manuel Garcia-Käufer; Yen-Hua Huang; Roman Huber; David J Craik; Gernot Schabbauer; Christian W Gruber
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

6.  COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.

Authors:  Tracy Yixin Chen; Sara Farghaly; Samantha Cham; Luis Lantigua Tatem; Jonathan H Sin; Roberto Rauda; Maria Ribisi; Nabil Sumrani
Journal:  Transpl Infect Dis       Date:  2020-07-06

Review 7.  The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections.

Authors:  Paulina Glowacka; Lidia Rudnicka; Olga Warszawik-Hendzel; Mariusz Sikora; Mohamad Goldust; Patrycja Gajda; Anna Stochmal; Leszek Blicharz; Adriana Rakowska; Malgorzata Olszewska
Journal:  Biology (Basel)       Date:  2020-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.